 | • レポートコード：MRC2-11QY12648 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はメニエール病のグローバル市場について調査・分析したレポートです。種類別（聴力検査、バランス評価、血液検査、画像検査、その他）市場規模、用途別（病院・クリニック、医学研究センター、学術機関、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別メニエール病の競争状況、市場シェア ・世界のメニエール病市場：種類別市場規模 2015年-2020年（聴力検査、バランス評価、血液検査、画像検査、その他） ・世界のメニエール病市場：種類別市場規模予測 2021年-2026年（聴力検査、バランス評価、血液検査、画像検査、その他） ・世界のメニエール病市場：用途別市場規模 2015年-2020年（病院・クリニック、医学研究センター、学術機関、その他） ・世界のメニエール病市場：用途別市場規模予測 2021年-2026年（病院・クリニック、医学研究センター、学術機関、その他） ・北米のメニエール病市場分析：米国、カナダ ・ヨーロッパのメニエール病市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのメニエール病市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のメニエール病市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのメニエール病市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Auris Medical、Jubilant Cadista、Otonomy、Prestige Brands Holdings、Sound Pharmaceuticals、The Ear Company、WellSpring Pharmaceutical ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Ménière’s disease (MD) is a disorder of the inner ear that is characterized by episodes of feeling like the world is spinning (vertigo), ringing in the ears (tinnitus), hearing loss, and a fullness in the ear. Typically only one ear is affected, at least initially; however, over time both ears may become involved. Episodes generally last from 20 minutes to a few hours. The time between episodes varies. The hearing loss and ringing in the ears may become constant over time.
There is no cure for Ménière’s disease but medications, diet, physical therapy and counseling, and some surgical approaches can be used to manage it.
Market Analysis and Insights: Global Meniere’s Disease Market
The global Meniere’s Disease market size is projected to reach US$ 4904.1 million by 2026, from US$ 4747 million in 2020, at a CAGR of 3.1%% during 2021-2026.
Global Meniere’s Disease Scope and Market Size
Meniere’s Disease market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Meniere’s Disease market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Auris Medical
Jubilant Cadista
Otonomy
Prestige Brands Holdings
Sound Pharmaceuticals
The Ear Company
WellSpring Pharmaceutical
…
Market segment by Type, the product can be split into
Hearing Assessment
Balance Assessment
Blood Tests
Imaging Test
Others
Market segment by Application, split into
Hospital And Clinics
Medical Research Centers
Academic Institutes
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Meniere’s Disease Revenue
1.4 Market by Type
1.4.1 Global Meniere’s Disease Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Hearing Assessment
1.4.3 Balance Assessment
1.4.4 Blood Tests
1.4.5 Imaging Test
1.4.6 Others
1.5 Market by Application
1.5.1 Global Meniere’s Disease Market Share by Application: 2020 VS 2026
1.5.2 Hospital And Clinics
1.5.3 Medical Research Centers
1.5.4 Academic Institutes
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Meniere’s Disease Market Perspective (2015-2026)
2.2 Global Meniere’s Disease Growth Trends by Regions
2.2.1 Meniere’s Disease Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Meniere’s Disease Historic Market Share by Regions (2015-2020)
2.2.3 Meniere’s Disease Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Meniere’s Disease Market Growth Strategy
2.3.6 Primary Interviews with Key Meniere’s Disease Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Meniere’s Disease Players by Market Size
3.1.1 Global Top Meniere’s Disease Players by Revenue (2015-2020)
3.1.2 Global Meniere’s Disease Revenue Market Share by Players (2015-2020)
3.1.3 Global Meniere’s Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Meniere’s Disease Market Concentration Ratio
3.2.1 Global Meniere’s Disease Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Meniere’s Disease Revenue in 2019
3.3 Meniere’s Disease Key Players Head office and Area Served
3.4 Key Players Meniere’s Disease Product Solution and Service
3.5 Date of Enter into Meniere’s Disease Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Meniere’s Disease Historic Market Size by Type (2015-2020)
4.2 Global Meniere’s Disease Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Meniere’s Disease Market Size by Application (2015-2020)
5.2 Global Meniere’s Disease Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Meniere’s Disease Market Size (2015-2020)
6.2 Meniere’s Disease Key Players in North America (2019-2020)
6.3 North America Meniere’s Disease Market Size by Type (2015-2020)
6.4 North America Meniere’s Disease Market Size by Application (2015-2020)
7 Europe
7.1 Europe Meniere’s Disease Market Size (2015-2020)
7.2 Meniere’s Disease Key Players in Europe (2019-2020)
7.3 Europe Meniere’s Disease Market Size by Type (2015-2020)
7.4 Europe Meniere’s Disease Market Size by Application (2015-2020)
8 China
8.1 China Meniere’s Disease Market Size (2015-2020)
8.2 Meniere’s Disease Key Players in China (2019-2020)
8.3 China Meniere’s Disease Market Size by Type (2015-2020)
8.4 China Meniere’s Disease Market Size by Application (2015-2020)
9 Japan
9.1 Japan Meniere’s Disease Market Size (2015-2020)
9.2 Meniere’s Disease Key Players in Japan (2019-2020)
9.3 Japan Meniere’s Disease Market Size by Type (2015-2020)
9.4 Japan Meniere’s Disease Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Meniere’s Disease Market Size (2015-2020)
10.2 Meniere’s Disease Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Meniere’s Disease Market Size by Type (2015-2020)
10.4 Southeast Asia Meniere’s Disease Market Size by Application (2015-2020)
11 India
11.1 India Meniere’s Disease Market Size (2015-2020)
11.2 Meniere’s Disease Key Players in India (2019-2020)
11.3 India Meniere’s Disease Market Size by Type (2015-2020)
11.4 India Meniere’s Disease Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Meniere’s Disease Market Size (2015-2020)
12.2 Meniere’s Disease Key Players in Central & South America (2019-2020)
12.3 Central & South America Meniere’s Disease Market Size by Type (2015-2020)
12.4 Central & South America Meniere’s Disease Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Auris Medical
13.1.1 Auris Medical Company Details
13.1.2 Auris Medical Business Overview
13.1.3 Auris Medical Meniere’s Disease Introduction
13.1.4 Auris Medical Revenue in Meniere’s Disease Business (2015-2020))
13.1.5 Auris Medical Recent Development
13.2 Jubilant Cadista
13.2.1 Jubilant Cadista Company Details
13.2.2 Jubilant Cadista Business Overview
13.2.3 Jubilant Cadista Meniere’s Disease Introduction
13.2.4 Jubilant Cadista Revenue in Meniere’s Disease Business (2015-2020)
13.2.5 Jubilant Cadista Recent Development
13.3 Otonomy
13.3.1 Otonomy Company Details
13.3.2 Otonomy Business Overview
13.3.3 Otonomy Meniere’s Disease Introduction
13.3.4 Otonomy Revenue in Meniere’s Disease Business (2015-2020)
13.3.5 Otonomy Recent Development
13.4 Prestige Brands Holdings
13.4.1 Prestige Brands Holdings Company Details
13.4.2 Prestige Brands Holdings Business Overview
13.4.3 Prestige Brands Holdings Meniere’s Disease Introduction
13.4.4 Prestige Brands Holdings Revenue in Meniere’s Disease Business (2015-2020)
13.4.5 Prestige Brands Holdings Recent Development
13.5 Sound Pharmaceuticals
13.5.1 Sound Pharmaceuticals Company Details
13.5.2 Sound Pharmaceuticals Business Overview
13.5.3 Sound Pharmaceuticals Meniere’s Disease Introduction
13.5.4 Sound Pharmaceuticals Revenue in Meniere’s Disease Business (2015-2020)
13.5.5 Sound Pharmaceuticals Recent Development
13.6 The Ear Company
13.6.1 The Ear Company Company Details
13.6.2 The Ear Company Business Overview
13.6.3 The Ear Company Meniere’s Disease Introduction
13.6.4 The Ear Company Revenue in Meniere’s Disease Business (2015-2020)
13.6.5 The Ear Company Recent Development
13.7 WellSpring Pharmaceutical
13.7.1 WellSpring Pharmaceutical Company Details
13.7.2 WellSpring Pharmaceutical Business Overview
13.7.3 WellSpring Pharmaceutical Meniere’s Disease Introduction
13.7.4 WellSpring Pharmaceutical Revenue in Meniere’s Disease Business (2015-2020)
13.7.5 WellSpring Pharmaceutical Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Meniere’s Disease Key Market Segments
Table 2. Key Players Covered: Ranking by Meniere’s Disease Revenue
Table 3. Ranking of Global Top Meniere’s Disease Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Meniere’s Disease Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Hearing Assessment
Table 6. Key Players of Balance Assessment
Table 7. Key Players of Blood Tests
Table 8. Key Players of Imaging Test
Table 9. Key Players of Others
Table 10. Global Meniere’s Disease Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Meniere’s Disease Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Meniere’s Disease Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Meniere’s Disease Market Share by Regions (2015-2020)
Table 14. Global Meniere’s Disease Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Meniere’s Disease Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Meniere’s Disease Market Growth Strategy
Table 20. Main Points Interviewed from Key Meniere’s Disease Players
Table 21. Global Meniere’s Disease Revenue by Players (2015-2020) (Million US$)
Table 22. Global Meniere’s Disease Market Share by Players (2015-2020)
Table 23. Global Top Meniere’s Disease Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Meniere’s Disease as of 2019)
Table 24. Global Meniere’s Disease by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Meniere’s Disease Product Solution and Service
Table 27. Date of Enter into Meniere’s Disease Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Meniere’s Disease Market Size by Type (2015-2020) (Million US$)
Table 30. Global Meniere’s Disease Market Size Share by Type (2015-2020)
Table 31. Global Meniere’s Disease Revenue Market Share by Type (2021-2026)
Table 32. Global Meniere’s Disease Market Size Share by Application (2015-2020)
Table 33. Global Meniere’s Disease Market Size by Application (2015-2020) (Million US$)
Table 34. Global Meniere’s Disease Market Size Share by Application (2021-2026)
Table 35. North America Key Players Meniere’s Disease Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Meniere’s Disease Market Share (2019-2020)
Table 37. North America Meniere’s Disease Market Size by Type (2015-2020) (Million US$)
Table 38. North America Meniere’s Disease Market Share by Type (2015-2020)
Table 39. North America Meniere’s Disease Market Size by Application (2015-2020) (Million US$)
Table 40. North America Meniere’s Disease Market Share by Application (2015-2020)
Table 41. Europe Key Players Meniere’s Disease Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Meniere’s Disease Market Share (2019-2020)
Table 43. Europe Meniere’s Disease Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Meniere’s Disease Market Share by Type (2015-2020)
Table 45. Europe Meniere’s Disease Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Meniere’s Disease Market Share by Application (2015-2020)
Table 47. China Key Players Meniere’s Disease Revenue (2019-2020) (Million US$)
Table 48. China Key Players Meniere’s Disease Market Share (2019-2020)
Table 49. China Meniere’s Disease Market Size by Type (2015-2020) (Million US$)
Table 50. China Meniere’s Disease Market Share by Type (2015-2020)
Table 51. China Meniere’s Disease Market Size by Application (2015-2020) (Million US$)
Table 52. China Meniere’s Disease Market Share by Application (2015-2020)
Table 53. Japan Key Players Meniere’s Disease Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Meniere’s Disease Market Share (2019-2020)
Table 55. Japan Meniere’s Disease Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Meniere’s Disease Market Share by Type (2015-2020)
Table 57. Japan Meniere’s Disease Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Meniere’s Disease Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Meniere’s Disease Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Meniere’s Disease Market Share (2019-2020)
Table 61. Southeast Asia Meniere’s Disease Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Meniere’s Disease Market Share by Type (2015-2020)
Table 63. Southeast Asia Meniere’s Disease Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Meniere’s Disease Market Share by Application (2015-2020)
Table 65. India Key Players Meniere’s Disease Revenue (2019-2020) (Million US$)
Table 66. India Key Players Meniere’s Disease Market Share (2019-2020)
Table 67. India Meniere’s Disease Market Size by Type (2015-2020) (Million US$)
Table 68. India Meniere’s Disease Market Share by Type (2015-2020)
Table 69. India Meniere’s Disease Market Size by Application (2015-2020) (Million US$)
Table 70. India Meniere’s Disease Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Meniere’s Disease Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Meniere’s Disease Market Share (2019-2020)
Table 73. Central & South America Meniere’s Disease Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Meniere’s Disease Market Share by Type (2015-2020)
Table 75. Central & South America Meniere’s Disease Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Meniere’s Disease Market Share by Application (2015-2020)
Table 77. Auris Medical Company Details
Table 78. Auris Medical Business Overview
Table 79. Auris Medical Product
Table 80. Auris Medical Revenue in Meniere’s Disease Business (2015-2020) (Million US$)
Table 81. Auris Medical Recent Development
Table 82. Jubilant Cadista Company Details
Table 83. Jubilant Cadista Business Overview
Table 84. Jubilant Cadista Product
Table 85. Jubilant Cadista Revenue in Meniere’s Disease Business (2015-2020) (Million US$)
Table 86. Jubilant Cadista Recent Development
Table 87. Otonomy Company Details
Table 88. Otonomy Business Overview
Table 89. Otonomy Product
Table 90. Otonomy Revenue in Meniere’s Disease Business (2015-2020) (Million US$)
Table 91. Otonomy Recent Development
Table 92. Prestige Brands Holdings Company Details
Table 93. Prestige Brands Holdings Business Overview
Table 94. Prestige Brands Holdings Product
Table 95. Prestige Brands Holdings Revenue in Meniere’s Disease Business (2015-2020) (Million US$)
Table 96. Prestige Brands Holdings Recent Development
Table 97. Sound Pharmaceuticals Company Details
Table 98. Sound Pharmaceuticals Business Overview
Table 99. Sound Pharmaceuticals Product
Table 100. Sound Pharmaceuticals Revenue in Meniere’s Disease Business (2015-2020) (Million US$)
Table 101. Sound Pharmaceuticals Recent Development
Table 102. The Ear Company Company Details
Table 103. The Ear Company Business Overview
Table 104. The Ear Company Product
Table 105. The Ear Company Revenue in Meniere’s Disease Business (2015-2020) (Million US$)
Table 106. The Ear Company Recent Development
Table 107. WellSpring Pharmaceutical Company Details
Table 108. WellSpring Pharmaceutical Business Overview
Table 109. WellSpring Pharmaceutical Product
Table 110. WellSpring Pharmaceutical Revenue in Meniere’s Disease Business (2015-2020) (Million US$)
Table 111. WellSpring Pharmaceutical Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Meniere’s Disease Market Share by Type: 2020 VS 2026
Figure 2. Hearing Assessment Features
Figure 3. Balance Assessment Features
Figure 4. Blood Tests Features
Figure 5. Imaging Test Features
Figure 6. Others Features
Figure 7. Global Meniere’s Disease Market Share by Application: 2020 VS 2026
Figure 8. Hospital And Clinics Case Studies
Figure 9. Medical Research Centers Case Studies
Figure 10. Academic Institutes Case Studies
Figure 11. Others Case Studies
Figure 12. Meniere’s Disease Report Years Considered
Figure 13. Global Meniere’s Disease Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global Meniere’s Disease Market Share by Regions: 2020 VS 2026
Figure 15. Global Meniere’s Disease Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Meniere’s Disease Market Share by Players in 2019
Figure 18. Global Top Meniere’s Disease Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Meniere’s Disease as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Meniere’s Disease Revenue in 2019
Figure 20. North America Meniere’s Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe Meniere’s Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China Meniere’s Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan Meniere’s Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia Meniere’s Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India Meniere’s Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America Meniere’s Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Bottom-up and Top-down Approaches for This Report
Figure 28. Data Triangulation
Figure 29. Key Executives Interviewed
メニエール病治療の世界市場（～2026年） Meniere’s disease is a disorder of middle ear that causes vertigo, ringing sound in the ear and hearing problems. In most of the cases this disease only affects one ear. Meniere’s disease can affect anyone but the prevalence is on a higher side in people aged from 20-50. This is a chronic disease bu…- メニエール病治療薬の世界市場（～2026年） Market Analysis and Insights: Global Meniere Disease Drugs Market The global Meniere Disease Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Meniere Disease Drugs Scope and Market Size Meniere Disease Drugs marke…
- 後天性孤児血液疾患の世界市場（～2026年） Acquired orphan blood disease is a type of rare blood disorder, which occurs due to the presence of insufficient amount of red blood cells in the blood. This disease is characterized by the body?s inability to produce red blood cells. Moreover, improper functioning of bone marrow also leads to lack …
- 呼吸器疾患検査/診断の世界市場（～2026年） Respiratory measuring devices, also known as respirometers, include respirometers, pulse oximeters, carbonic acid meters, and peak flow meters. The prevalence of respiratory diseases such as chronic obstructive pulmonary disease, asthma and other respiratory infections, as well as the increasing pop…
- クローン病診断・治療の世界市場（～2026年） Crohn's disease is a type of inflammatory bowel disease (IBD) that may affect any part of the gastrointestinal tract from mouth to anus. Signs and symptoms often include abdominal pain, diarrhea, fever, and weight loss. As the prevalence of the disease increases, it is expected to drive the Crohn's …